294
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

LC, LC-MS/MS STUDIES FOR IDENTIFICATION AND CHARACTERIZATION OF DEGRADATION PRODUCTS OF LAMOTRIGINE AND ESTABLISHMENT OF MECHANISTIC APPROACH TOWARDS DEGRADATION

, , &
Pages 2255-2271 | Published online: 05 Oct 2012
 

Abstract

The objective of present investigation was to separate, identify, and characterize the degradation products of lamotrigine under hydrolytic, oxidative, photolytic, and thermal stress conditions as per International Conference on Harmonization (ICH) guideline Q1A (R2). The drug underwent degradation under acidic, basic, and oxidative stress, while it was stable in photolytic and thermal stress conditions. A total four degradation products were formed which were separated by using HPLC on C18 column using gradient elution program. A complete mass fragmentation pattern of the drug was first established with the help of LC-MS/MS studies. The stressed samples were subjected to LC-MS/MS studies. The obtained mass spectral data were employed to characterize three degradation products and assign structures. Complete information was used to establish the degradation pathway of the drug. The degradation products were identified as 3-amino-6-(2, 3-dichlorophenyl)-1, 2, 4-triazin-5(4H)-one, 6-(2, 3-Dichloro-phenyl)-2-oxy-[1, 2, 4] triazine-3, 5-diamine, 6-(2, 3-Dichloro-phenyl)-4-oxy-[1, 2, 4] triazine-3, 5-diamine.

ACKNOWLEDGMENT

Authors wish to thank DBT-ICT Center for Energy Biosciences, Mumbai for conducting LC-MS/MS studies.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.